Webinar
November 20, 2025 at 1:00 PM ET
Online
WEbinar
November 20, 2025 at 1:00 PM ET
Online
Webinar
November 20, 2025 at 1:00 PM ET
Online
Overview
Why attend this webinar?
As psychedelic therapy grows, clinicians and practitioners face not only clinical questions but also complex financial and regulatory considerations. This webinar will explore key financial strategies for running a sustainable practice, with a focus on compliance, planning, and growth. Attendees will gain insights into navigating business structures, tax considerations, and financial planning while building a responsible and scalable practice.
In this webinar, we’ll be joined by Justin Botillier, founder of Calyx CPA, an accounting and advisory firm with a focus on the unique needs of professionals working in the emerging field of psilocybin services. Justin Botillier brings over twenty years of experience working with small business owners and entrepreneurs. He was an early advocate for the cannabis industry and, in 2016, shifted his focus full-time to supporting plant medicine businesses. Today, Justin works with psychedelic therapy practitioners and psilocybin businesses to navigate the financial complexities of operating in federally regulated spaces.
A central part of the discussion will focus on IRS Code Section 280E, a tax provision that penalizes businesses engaged in federally illegal “drug trafficking.” Misunderstandings about 280E often lead to unnecessary fear and even overpayment of taxes. The webinar will clarify what 280E really means for psychedelic therapy businesses and highlight legal strategies to reduce its impact.
This conversation will highlight:
Key financial and operational considerations for psychedelic therapy practices.
How to navigate compliance, regulation, and taxation in this new field.
Strategies for building a sustainable practice that balances accessibility with viability.
Best practices for managing finances in psychedelic therapy practices
Legal and tax considerations for businesses operating in federally regulated spaces
This CE-granting session will benefit clinicians, students, researchers, and anyone interested in how psychedelic-assisted therapy is evolving across contexts.
The webinar will conclude with a live Q&A. A recording will be sent to everyone who registers, so sign up even if you can’t attend live.
Continuing Education Information
Learning Objectives
By the end of this program, participants will be able to:
Key financial and operational considerations for psychedelic therapy practices.
How to navigate compliance, regulation, and taxation in this new field.
Strategies for building a sustainable practice that balances accessibility with viability.
Best practices for managing finances in psychedelic therapy practices
Legal and tax considerations for businesses operating in federally regulated spaces
Instructional Level: Intermediate. This program is intended for mental health professionals with foundational knowledge of psychotherapy.
Target Audience: Psychologists, social workers, counselors, psychiatrists, and other licensed mental health professionals interested in evidence-based practices in psychedelic-assisted therapy.
Continuing Education Credit: This live webinar offers 1 CE hour. CE credit is only available for live attendance; participants must attend the full session to receive credit.
Accreditation and Eligibility: https://www.fluencetraining.com/about/continuing-education
Disclosure: The presenters have no relevant financial or commercial conflicts of interest to disclose.
Type
Webinar
Overview
Why attend this webinar?
As psychedelic therapy grows, clinicians and practitioners face not only clinical questions but also complex financial and regulatory considerations. This webinar will explore key financial strategies for running a sustainable practice, with a focus on compliance, planning, and growth. Attendees will gain insights into navigating business structures, tax considerations, and financial planning while building a responsible and scalable practice.
In this webinar, we’ll be joined by Justin Botillier, founder of Calyx CPA, an accounting and advisory firm with a focus on the unique needs of professionals working in the emerging field of psilocybin services. Justin Botillier brings over twenty years of experience working with small business owners and entrepreneurs. He was an early advocate for the cannabis industry and, in 2016, shifted his focus full-time to supporting plant medicine businesses. Today, Justin works with psychedelic therapy practitioners and psilocybin businesses to navigate the financial complexities of operating in federally regulated spaces.
A central part of the discussion will focus on IRS Code Section 280E, a tax provision that penalizes businesses engaged in federally illegal “drug trafficking.” Misunderstandings about 280E often lead to unnecessary fear and even overpayment of taxes. The webinar will clarify what 280E really means for psychedelic therapy businesses and highlight legal strategies to reduce its impact.
This conversation will highlight:
Key financial and operational considerations for psychedelic therapy practices.
How to navigate compliance, regulation, and taxation in this new field.
Strategies for building a sustainable practice that balances accessibility with viability.
Best practices for managing finances in psychedelic therapy practices
Legal and tax considerations for businesses operating in federally regulated spaces
This CE-granting session will benefit clinicians, students, researchers, and anyone interested in how psychedelic-assisted therapy is evolving across contexts.
The webinar will conclude with a live Q&A. A recording will be sent to everyone who registers, so sign up even if you can’t attend live.
Continuing Education Information
Learning Objectives
By the end of this program, participants will be able to:
Key financial and operational considerations for psychedelic therapy practices.
How to navigate compliance, regulation, and taxation in this new field.
Strategies for building a sustainable practice that balances accessibility with viability.
Best practices for managing finances in psychedelic therapy practices
Legal and tax considerations for businesses operating in federally regulated spaces
Instructional Level: Intermediate. This program is intended for mental health professionals with foundational knowledge of psychotherapy.
Target Audience: Psychologists, social workers, counselors, psychiatrists, and other licensed mental health professionals interested in evidence-based practices in psychedelic-assisted therapy.
Continuing Education Credit: This live webinar offers 1 CE hour. CE credit is only available for live attendance; participants must attend the full session to receive credit.
Accreditation and Eligibility: https://www.fluencetraining.com/about/continuing-education
Disclosure: The presenters have no relevant financial or commercial conflicts of interest to disclose.
Type
Webinar
Overview
Why attend this webinar?
As psychedelic therapy grows, clinicians and practitioners face not only clinical questions but also complex financial and regulatory considerations. This webinar will explore key financial strategies for running a sustainable practice, with a focus on compliance, planning, and growth. Attendees will gain insights into navigating business structures, tax considerations, and financial planning while building a responsible and scalable practice.
In this webinar, we’ll be joined by Justin Botillier, founder of Calyx CPA, an accounting and advisory firm with a focus on the unique needs of professionals working in the emerging field of psilocybin services. Justin Botillier brings over twenty years of experience working with small business owners and entrepreneurs. He was an early advocate for the cannabis industry and, in 2016, shifted his focus full-time to supporting plant medicine businesses. Today, Justin works with psychedelic therapy practitioners and psilocybin businesses to navigate the financial complexities of operating in federally regulated spaces.
A central part of the discussion will focus on IRS Code Section 280E, a tax provision that penalizes businesses engaged in federally illegal “drug trafficking.” Misunderstandings about 280E often lead to unnecessary fear and even overpayment of taxes. The webinar will clarify what 280E really means for psychedelic therapy businesses and highlight legal strategies to reduce its impact.
This conversation will highlight:
Key financial and operational considerations for psychedelic therapy practices.
How to navigate compliance, regulation, and taxation in this new field.
Strategies for building a sustainable practice that balances accessibility with viability.
Best practices for managing finances in psychedelic therapy practices
Legal and tax considerations for businesses operating in federally regulated spaces
This CE-granting session will benefit clinicians, students, researchers, and anyone interested in how psychedelic-assisted therapy is evolving across contexts.
The webinar will conclude with a live Q&A. A recording will be sent to everyone who registers, so sign up even if you can’t attend live.
Continuing Education Information
Learning Objectives
By the end of this program, participants will be able to:
Key financial and operational considerations for psychedelic therapy practices.
How to navigate compliance, regulation, and taxation in this new field.
Strategies for building a sustainable practice that balances accessibility with viability.
Best practices for managing finances in psychedelic therapy practices
Legal and tax considerations for businesses operating in federally regulated spaces
Instructional Level: Intermediate. This program is intended for mental health professionals with foundational knowledge of psychotherapy.
Target Audience: Psychologists, social workers, counselors, psychiatrists, and other licensed mental health professionals interested in evidence-based practices in psychedelic-assisted therapy.
Continuing Education Credit: This live webinar offers 1 CE hour. CE credit is only available for live attendance; participants must attend the full session to receive credit.
Accreditation and Eligibility: https://www.fluencetraining.com/about/continuing-education
Disclosure: The presenters have no relevant financial or commercial conflicts of interest to disclose.
Type
Webinar
Grow your practice.
Get certified and join the Fluence Psychedelic Therapy Directory—where clients find trusted experts.
Grow your practice.
Get certified and join the Fluence Psychedelic Therapy Directory—where clients find trusted experts.
Grow your practice.
Get certified and join the Fluence Psychedelic Therapy Directory—where clients find trusted experts.
What students have to say about our programs...
I really appreciate Fluence. The trainings and coursework, the literature shared, the community, self-development and insightful explorations have strengthened me as a professional and given such a sense of competence in this evolving space.
Amy Johnson
LCSW
I've been more than thrilled about my experience with Fluence thus far. I am a ketamine-assisted psychotherapist and
continue to learn more information and modalities to incorporate into my practice, from both the instructors and
fellow students.
LAURA HUTCHINS,
LCMHC, LCAS, KAP Consulting
My entire experience with Fluence has been exceptional. The instructors are giants in the psychedelic field, many are active in clinical research and you will see their names in scientific publications.
Stephanie Barss,
FNP, PMHNP, Psilocybin-Assisted Therapy
Certificate Program Advisor
The trainers at Fluence are what continually confirm that I am in the right place. The reverence and honor with which they approach their work is so evident. I have felt a sense of safety
at Fluence that is not present in other organizations I have
trained with or researched, and it is the trainers who create that safety.
Andrea Bigenho,
LPC specialist in Psychedelic Integration
What are students say…
I really appreciate Fluence. The trainings and coursework, the literature shared, the community, self-development and insightful explorations have strengthened me as a professional and given such a sense of competence in this evolving space.
Amy Johnson,
LCSW
What students have to say about our programs...
I really appreciate Fluence. The trainings and coursework, the literature shared, the community, self-development and insightful explorations have strengthened me as a professional and given such a sense of competence in this evolving space.
Amy Johnson,
LCSW
Authorized provider of continuing education.
Fluence is approved by the American Psychological Association to sponsor continuing education for psychologists.
Fluence maintains responsibility for this program and its content.
Authorized provider of continuing education.
Fluence is approved by the American Psychological Association to sponsor continuing education for psychologists.
Fluence maintains responsibility for this program and its content.
Authorized provider of continuing education.
Fluence is approved by the American Psychological Association to sponsor continuing education for psychologists.
Fluence maintains responsibility for this program and its content.
Subscribe to our newsletter!
Professional Certificates
Email Us:
Subscribe to our newsletter!
Professional Certificates
Email Us:
Subscribe to our newsletter!
Professional Certificates
Email Us: